Sculptor Capital’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Sculptor Capital’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-199,100	Closed	-$4.27K	–	611
2023 Q1	$4.27K	Hold	199,100	–	–	﹤0.01%	511
2022 Q4	$27.2K	Hold	199,100	–	–	﹤0.01%	588
2022 Q3	$32K	Hold	199,100	–	–	﹤0.01%	829
2022 Q2	$31K	Sell	199,100 -100	-0.1%	-$49	﹤0.01%	964
2022 Q1	$156K	Sell	199,200 -800	-0.4%	-$560	﹤0.01%	879
2021 Q4	$123K	Sell	200,000 -79,968	-29%	-$81.2K	﹤0.01%	942
2021 Q3	$257K	Hold	279,968	–	–	﹤0.01%	706
2021 Q2	$402K	Buy	279,968 +213,302	+320%	+$186K	﹤0.01%	664
2021 Q1	$55K	Buy	+66,666	New	+$65K	﹤0.01%	668

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Sculptor Capital's PEARW Position: Q2 2023 in Review

Sculptor Capital sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 199,100 shares — an estimated $4.27K sold.

Sculptor Capital first reported a position in PEARW in Q1 2021 and held it in 9 quarters. The position peaked at $402K in Q2 2021. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Sculptor Capital reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Sculptor Capital sold 199,100 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $4.27K.
Sculptor Capital first reported a position in Pear Therapeutics, Inc. Warrant in Q1 2021 and held it in 9 quarters.
Sculptor Capital's Pear Therapeutics, Inc. Warrant position peaked at $402K in Q2 2021.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Sculptor Capital's 13F filing for Q2 2023, filed 14 Aug 2023.